Basic Information
OXYCODONE KALCEKS SOLUTION FOR INJECTION OR INFUSION 10 MG/ML
INJECTION, SOLUTION
Regulatory Information
SIN16635P
November 4, 2022
Prescription Only
Therapeutic
INTRAVENOUS, SUBCUTANEOUS
August 10, 2023
June 3, 2025
XN02AA05
Company Information
Active Ingredients
Strength: 10.0mg/ml
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to oxycodone or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_. Oxycodone must not be used in any situation where opioids are contraindicated: - known sensitivity to morphine or other opioids; - severe respiratory depression with hypoxia; - head injury; - chronic obstructive airways disease; - cor pulmonale; - severe bronchial asthma; - moderate or severe hepatic impairment; - severe renal impairment (creatinine clearance < 10 ml/min); - elevated carbon dioxide levels in the blood; - paralytic ileus; - acute abdomen; - chronic constipation; - concurrent administration of monoamine oxidase (MAO) inhibitors or within 2 weeks of discontinuation of their use; - pregnancy.
Indication Information
**4.1 Therapeutic indications** For the treatment of moderate to severe pain in patients with cancer and postoperative pain. For the treatment of severe pain requiring the use of a strong opioid. OXYCODONE KALCEKS is indicated in adults only.